Substance Use Disorders (SUDs)
Conditions
Keywords
digital therapeutics, substance use disorders, development platform
Brief summary
This is a research study to evaluate the usability of the Cogito digital therapeutics development platform. The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide the components for building a digital therapeutic for any health condition and population. And in this initial study, the research team plans to examine the usability of Cogito in building a digital therapeutic for substance use disorders (SUDs).
Detailed description
Each participant will be asked to: * Complete an interactive tutorial describing what Cogito is and how to create a sample guide, sample activities, and a sample survey. * Explore using the various Cogito processes by completing a functionality scavenger hunt. In this scavenger hunt, participants will be walked through a series of activities to create new guides, activities and surveys. * Complete surveys to provide feedback on participants' experience using Cogito
Interventions
OTHERCogito digital therapeutics development platform
Cogito will provide a turnkey solution for rapidly developing, evaluating, deploying, and scaling digital therapeutics for the prevention, treatment and/or management of any disease or disorder. This platform will allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide all the components for building a digital therapeutic for any health condition and population. Overall, Cogito offers great promise to markedly accelerate the pace and impact of science based digital therapeutics.
Sponsors
National Institute on Drug Abuse (NIDA)
Square2 Systems, Inc.
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* At least 18 years * PhD and/or MD-level (or equivalent) scientists at academic institutions or digital health companies at the level of Post-doctoral Fellow or higher. * Training or trained in substance use disorder (SUDs) research. * Must state a specific interest in digital therapeutics for SUDs.
Exclusion criteria
* Those who do not meet inclusion criteria.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| System Usability Scale | To be completed immediately after usability feedback session | Each participant will be asked to complete the standardized 10-item System Usability Scale (SUS) to evaluate the usability of Cogito (e.g., I think I would like to use this system frequently), ranging from strongly agree to strongly disagree. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analog Scales | To be completed immediately after usability feedback session | 100 mm Visual Analog measures, ranging from Not at All anchored at 0 to Very anchored at 100 for each question, with every question worded positively to assess how (1) easy to use, (2) understandable, (3) likable, (4) useful (5) relevant they found the Cogito development functionality in each stage of the scavenger hunt as well as (6) how likely they would be to use Cogito as a digital therapeutics development and hosting platform. |
Countries
United States
Contacts
Primary ContactSquare2 Systems
Outcome results
None listed